United State Pharmacopeia

Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1of 42

UNITED STATES PHARMACOPEIA

Presented by
2167,2168,2169,2178,
2188,2189

CONTENTS
Pharmacopeia
United State Pharmacopeia
History
Volumes of USP
Importance of USP
Landmark Achievements by USP
Monograph

PHARMACOPEIA

An official publication containing a list of

drugs with their effects and directions


for their use.

It can be defined as;


Abookpublishedusuallyunderthe
jurisdictionofthegovernment and
containing
a list of drugs,
their formulas,
methods for makingmedicinal

preparations,
requirementsandtestsfortheir
strengthandpurity,
and otherrelatedinformation

UNITED STATES
PHARMACOPEIA
scientific nonprofit organization

sets standards for the identity,

strength, quality, and purity of


medicines, food ingredients, and
dietary supplements manufactured,
distributed and consumed worldwide.

USPs drug standards are enforceable in

the United States by the Food and Drug


Administration, and these standards are
used in more than 140 countries.

HISTORY
1820

founded in Washington, DC..


1830

Committee of Revision created (seven


members).
First revision of the USP published;
revisions continue at 10-year intervals.

1848

official compendium.
1850

Colleges of pharmacy participated in


revision.
1888

NF published by the American


Pharmacists Association.

Conti
1900
not-for-profit corporation.

1906

FDA passed USP and NF standards


1932

Reference Standards program


succeeded

1938

FDA approves drugs for safety before


marketing.
1942

USP revision cycle changed; USP


published every five years.

Conti
1963

First USAN cumulative list published.


1971

USP moves to Rockville, MD, USA.


1975

USP acquires National Formulary and


Drug Standards Laboratory from APhA.

1977

USP and NF scope redefined


1980

USP Dispensing Information (USP


DI) published.

Conti
1992

long-term collaboration with USAID.


1993

Federal Omnibus Budget Reconciliation


Acts (OBRA '90 and '93) rename USP DI.

1998

USP licensed USP DI and associated


products
2001

USP launches the Dietary Supplement


Verification Program.
2002

USPNF published annually

Conti
2004

first joint symposium in China.


2009

publication of USP Dietary Supplements


Compendium.
2011

USP/PQM registers in Ethiopia as a nongovernmental organization.

2012

USPNF translated into Chinese.


2013

new logo and tagline to celebrate and


emphasize the global scope of our work
USP creates the Herbal Medicines
Compendium.
2014

USPChina site expands to a 95,000 sq. ft.


facility with state-of-the-art laboratories.

Volumes of USP
Volume I:

Drug Information for the


Health Care Professional

Volume II:
Volume III:

Advice for the Patient.

Approved Drug Products


and Legal Requirements

USP Volumes I and II are available

through
MICROMEDEX Healthcare Series, in
printed books, or
Desktop Series CD-ROM.
USP DI Volume III is available in a

printed book only.

Volume 1
Drug Information for the Health
Care Professional.
o brand names
o Categorization
o Indications
o chemistry (chemical names, molecular
formulas, molecular weights, physical
characteristics, solubility)

opharmacology (mechanisms of

action and effects, absorption,


protein binding, elimination)
o precautions in use (including
drug interactions)
o contraindications,
omonitoring side and adverse

Volume 2
Advice For The Patient
o Important drug facts .
o Includes a Glossary of Medical Terms

and a list of Poison Control Centers


o It is an Invaluable Resource for Patient
Education
o Printed in large type and written in
patient-friendly language.

Conti
o Simplified drug monographs provide

direct, reassuring guidance on:


Proper drug use
Precautions
Side effects
Special considerations such as age,
allergies, pregnancy, breastfeeding
And more

VOLUME 3
Approved drug products and legal

requirements
o Quickly find information on which generic
drugs can be safely substituted for brand
name drugs
o important compounding information,
o drugs that have been discontinued,
o orphan drugs,
o purity and storage standards,
o as well as a manufacturer listing with their
approved drugs.

This valuable reference includes the

complete contents of the FDA's Orange


Book: Approved Drug Products with
Therapeutic Equivalence Evaluations.
It also features regarding quality,
packaging, storing and labeling
requirements, and color pill charts which
can help quickly identify pills and
capsules.

Importance of USP
USP along with FDA have the same

goals to ensure the quality of


products in the U.S. market place so
that a physician and a patient can rely
on them to treat a given indication.

The USP is primarily concerned with the

dosage form.
The FDA, in addition to dosage forms, is

also concerned about the drug


development process--how it is
manufactured, the purity of the
conditions under which it is
manufactured, and the protection of
the human subjects during the drug
testing phase.

Conti
The USP is in responsible for drug

chemistry, purity, strength,


formulation and the kinds of tests
that are done to ensure a drug is a
quality product in the U.S. marketplace.
It sets the U.S. standard, and since the
U.S. is ahead of the rest of the world, its
quality standards become guidelines for
many other countries as well.

Physicians originally set up the USP standards

in 1820.
They were primarily published and revised by
physicians every ten years from that period
until about the 1880s.
That is when it really became a pharmacy
publication with pharmacists, chemists, and
physicians involved in the revision process.

Landmark
Achievements
The greatest achievement is
the reliability of products in the U.S.

marketplace.

Monographs
Monograph of ACETIC ACID
Acetic acid

Acetic acid is a solution containing not


less than 36.0% and not more than
37.0% by weight of C2H4O2
Packaging and storage:
Preserve in tight containers

Identification:

It responds to the tests for acetate.


Non volatile residue:

Evaporate 20ml in a tared porcelain


dish on a steam bath and dry it 105C
for 1 hr: the weight of the residue does
not exceed 1.0 mg (0.005 %).

Conti
Chloride:

Add five drops of silver nitrate TS to


10 ml of a solution (1 in 10): no
opalescence is produced.
Sulfate:
Add 5 drops of barium chloride TS to
10ml of a solution (1 in 10): no turbidity
is produced.

Heavy metal:

To the residue obtained in the test for


non volatile residue add 8ml of 0.1 N HCl
warm gently until solution is complete,
dilute with water to 100 ml, and use
10ml of the solution: the limit is 0.001%.

Readily oxidized able substances:

Dilute 4.0ml in a glass-stop- pered vessel


with 20ml of water and add 0.30ml of 0.10N
potassium permanganate: the pink color is not
changed to brown at once, and the liquid does
not become entirely brown or free from pink
tint in less than 30 seconds.

Conti
Organic volatile impurities:
Meets the requirements.
Assay:
Place about 6ml of acetic acid in a
tared , glass-stop-pered flask ,and
weigh accurately .Add 40ml of water,
then add phenolphthalein TS ,and titrate
with 1N sodium hydroxide VS. Each ml
of 1N sodium hydroxide is equivalent to
60.05mg of C2H4O2.

Difference of BP & USP


BRITISH
PHARMACOPOEIA
The BP

contributes
significantly to
the overall control
of the quality of
medicinal
products.

UNITED STATES
PHARMACOPOEIA
The USP is primarily

concerned with the


dosage form, drug
development
process ,purity of
the conditions ,the
protection of the
human subjects

providing an

authoritative
statement of the
quality of that
product
collection of
quality standards
forUKmedicinals
ubstances

contains a list of
drugs, their
formulas, methods
for
makingmedicinal
preparations,
requirementsand
testsfortheir
strengthandpurity,
and
otherrelatedinform
ation.

References
USP30-NF25
Dr.

Jerome Skelly, Past Presidentat American


Association of Pharmaceutical Sciences (AAPS).

You might also like